Neuronetics Statistics
Share Statistics
Neuronetics has 32.07M shares outstanding. The number of shares has increased by 7.77% in one year.
| Shares Outstanding | 32.07M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 5.84% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 15.66M |
| Failed to Deliver (FTD) Shares | 675 |
| FTD / Avg. Volume | 0.11% |
Short Selling Information
The latest short interest is 735.04K, so 2.29% of the outstanding shares have been sold short.
| Short Interest | 735.04K |
| Short % of Shares Out | 2.29% |
| Short % of Float | 4.7% |
| Short Ratio (days to cover) | 4.05 |
Valuation Ratios
The PE ratio is -2.75 and the forward PE ratio is -0.98.
| PE Ratio | -2.75 |
| Forward PE | -0.98 |
| PS Ratio | 1.16 |
| Forward PS | 0.8 |
| PB Ratio | 2.43 |
| P/FCF Ratio | -2.42 |
| PEG Ratio | n/a |
Enterprise Valuation
Neuronetics Inc. has an Enterprise Value (EV) of 85.91M.
| EV / Earnings | -2.85 |
| EV / Sales | 1.2 |
| EV / EBITDA | -3.77 |
| EV / EBIT | -2.81 |
| EV / FCF | -2.5 |
Financial Position
The company has a current ratio of 4.73, with a Debt / Equity ratio of 1.76.
| Current Ratio | 4.73 |
| Quick Ratio | 4.33 |
| Debt / Equity | 1.76 |
| Total Debt / Capitalization | 63.75 |
| Cash Flow / Debt | -0.53 |
| Interest Coverage | -5.63 |
Financial Efficiency
Return on equity (ROE) is -0.88% and return on capital (ROIC) is -31.58%.
| Return on Equity (ROE) | -0.88% |
| Return on Assets (ROA) | -0.26% |
| Return on Capital (ROIC) | -31.58% |
| Revenue Per Employee | 351.47K |
| Profits Per Employee | -148.71K |
| Employee Count | 203 |
| Asset Turnover | 0.62 |
| Inventory Turnover | 2.43 |
Taxes
| Income Tax | -24.00K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -28.67% in the last 52 weeks. The beta is 2.22, so Neuronetics 's price volatility has been higher than the market average.
| Beta | 2.22 |
| 52-Week Price Change | -28.67% |
| 50-Day Moving Average | 1.21 |
| 200-Day Moving Average | 1.75 |
| Relative Strength Index (RSI) | 71.93 |
| Average Volume (20 Days) | 593.91K |
Income Statement
In the last 12 months, Neuronetics had revenue of 71.35M and earned -30.19M in profits. Earnings per share was -1.05.
| Revenue | 71.35M |
| Gross Profit | 51.70M |
| Operating Income | -30.55M |
| Net Income | -30.19M |
| EBITDA | -22.76M |
| EBIT | -30.55M |
| Earnings Per Share (EPS) | -1.05 |
Balance Sheet
The company has 59.68M in cash and 62.47M in debt, giving a net cash position of -2.80M.
| Cash & Cash Equivalents | 59.68M |
| Total Debt | 62.47M |
| Net Cash | -2.80M |
| Retained Earnings | -376.08M |
| Total Assets | 74.12M |
| Working Capital | 36.56M |
Cash Flow
In the last 12 months, operating cash flow was -32.04M and capital expenditures -2.37M, giving a free cash flow of -34.41M.
| Operating Cash Flow | -32.04M |
| Capital Expenditures | -2.37M |
| Free Cash Flow | -34.41M |
| FCF Per Share | -1.2 |
Margins
Gross margin is 72.47%, with operating and profit margins of -42.82% and -42.31%.
| Gross Margin | 72.47% |
| Operating Margin | -42.82% |
| Pretax Margin | -42.31% |
| Profit Margin | -42.31% |
| EBITDA Margin | -31.9% |
| EBIT Margin | -42.82% |
| FCF Margin | -48.22% |
Dividends & Yields
STIM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -49.07% |
| FCF Yield | -50.14% |
Analyst Forecast
The average price target for STIM is $3, which is 40.2% higher than the current price. The consensus rating is "Buy".
| Price Target | $3 |
| Price Target Difference | 40.2% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
Scores
| Altman Z-Score | -6.94 |
| Piotroski F-Score | 3 |